Antagonistic A2a/D2 receptor interactions in the striatum as a basis for adenosine/dopamine interactions in the central nervous system

From behavioural and biochemical experiments, we have found evidence for the existence of a specific adenosine A2a receptor/dopamine D2 receptor interaction in the brain. Behavioural data show that stimulation A2a receptors inhibits and their blockade potentiates a D2‐mediated locomotor activation in mice and that stimulation of D2 receptors counteracts on A2a mediated cataleptic effect in rats. Biochemical data show that, in rat striatal membrane preparations, A2a receptor stimulation decreases the affinity of D2 receptors and the transduction of the signal from the D2 receptor to the G‐protein. Based on these findings it is postulated that this A2a/D2 interaction might be the main mechanism responsible for the central effects of adenosine agonists and antagonists, like methylxanthines. The increased behavioural effect of methylxanthines after dopamine denervation could be explained by an increased interaction between adenosine A2a and dopamine D2 receptors. Membrane preparations‐denervated striatum are more sensitive to the effect of adenosine A2a receptor stimulation. Our results underline the potential antiparkinsonian action of adenosine A2a antagonists and the potential antipsychotic of adenosine A2a agonists. © 1993 Wiley‐Liss, Inc.

[1]  S. Ferré,et al.  Is experimental catalepsy properly measured? , 1990, Pharmacology Biochemistry and Behavior.

[2]  U. Ungerstedt,et al.  Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice. , 1991, European journal of pharmacology.

[3]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[4]  M. Williams,et al.  Autoradiographic characterization of high-affinity adenosine A2 receptors in the rat brain , 1989, Brain Research.

[5]  B. Bloch,et al.  Dopamine receptor gene expression by enkephalin neurons in rat forebrain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Adams,et al.  Monoamine synthesis and caffeine-induced locomotor activity , 1978, Neuropharmacology.

[7]  D. Sibley,et al.  Regulation of ligand binding to pituitary D-2 dopaminergic receptors. Effects of divalent cations and functional group modification. , 1983, The Journal of biological chemistry.

[8]  R. D. Green,et al.  Modulation of striatal dopaminergic function by local injection of 5'-N-ethylcarboxamide adenosine. , 1982, Science.

[9]  K. Fuxe,et al.  Stimulation of adenosine A2 receptors induces catalepsy , 1991, Neuroscience Letters.

[10]  U. Ungerstedt,et al.  Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice. , 1991, European journal of pharmacology.

[11]  J. Meldolesi,et al.  Mechanisms of signal transduction at the dopamine D2 receptor. , 1989, Trends in pharmacological sciences.

[12]  U. Ungerstedt,et al.  On the mechanism by which methylxanthines enhance apomorphine-induced rotation behaviour in the rat , 1983, Pharmacology Biochemistry and Behavior.

[13]  Margarete Müller,et al.  ADENOSINE REGULATES VIA TWO DIFFERENT TYPES OF RECEPTORS, THE ACCUMULATION OF CYCLIC AMP IN CULTURED BRAIN CELLS , 1979, Journal of neurochemistry.

[14]  N. Andén,et al.  Stimulation of D1 dopamine receptors reveals direct effects of the preferential dopamine autoreceptor agonist B-HT 920 on postsynaptic dopamine receptors. , 1988, Acta physiologica Scandinavica.

[15]  B B Fredholm,et al.  Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[16]  G. Ghai,et al.  CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity. , 1989, Journal of Pharmacology and Experimental Therapeutics.

[17]  S. Fuchs,et al.  Phosphorylation by Cyclic AMP‐Dependent Protein Kinase Modulates Agonist Binding to the D2 Dopamine Receptor , 1991, Journal of neurochemistry.

[18]  Luigi F. Agnati,et al.  Receptor‐receptor interactions in the central nervous system. A new integrative mechanism in synapses , 1985, Medicinal research reviews.

[19]  S. Schiffmann,et al.  Striatal Restricted Adenosine A2 Receptor (RDC8) Is Expressed by Enkephalin but Not by Substance P Neurons: An In Situ Hybridization Histochemistry Study , 1991, Journal of neurochemistry.

[20]  T. Dunwiddie,et al.  Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. , 1990, The Journal of pharmacology and experimental therapeutics.

[21]  S. R. Snodgrass,et al.  Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine , 1986, Pharmacology Biochemistry and Behavior.

[22]  S Schiffmann,et al.  RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. , 1990, Biochemical and biophysical research communications.

[23]  J. Palacios,et al.  Adenosine A2 receptors: Selective localization in the human basal ganglia and alterations with disease , 1991, Neuroscience.

[24]  Sheena A. Josselyn,et al.  Behavioral effects of intrastriatal caffeine mediated by adenosinergic modulation of dopamine , 1991, Pharmacology Biochemistry and Behavior.

[25]  K. Fuxe,et al.  Effect of some phosphodiesterase inhibitors on central dopamine mechanisms. , 1976, European journal of pharmacology.

[26]  U. Ungerstedt,et al.  Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. , 1971, Acta physiologica Scandinavica. Supplementum.

[27]  M. Williams,et al.  [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. , 1989, The Journal of pharmacology and experimental therapeutics.

[28]  B. Fredholm,et al.  Are methylxanthine effects due to antagonism of endogenous adenosine , 1979 .

[29]  B. Bloch,et al.  D2 dopamine receptor gene expression by cholinergic neurons in the rat striatum , 1990, Neuroscience Letters.

[30]  K. Fuxe,et al.  Dopamine denervation leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum , 1992, Brain Research.